Literature DB >> 17215337

Relationship between HLA polymorphisms and gamma interferon and interleukin-10 cytokine production in healthy individuals after rubella vaccination.

Inna G Ovsyannikova1, Robert M Jacobson, Jenna E Ryan, Neelam Dhiman, Robert A Vierkant, Gregory A Poland.   

Abstract

We studied the association between HLA alleles and rubella-specific gamma interferon (IFN-gamma) (Th1) and interleukin-10 (IL-10) (Th2) cytokine responses among 106 healthy children (ages, 14 to 17 years) previously immunized with two doses of rubella vaccine. Antibody titers and cytokine responses to rubella vaccination were not sex or age dependent. Several class I HLA-A (*0201, *2402, *6801) alleles were significantly associated with rubella vaccine-induced IFN-gamma secretion. Several class II HLA-DRB1 (*0101) and HLA-DQB1 (*0501) alleles were also suggestive of an association with IFN-gamma secretion. Alleles with potential associations with rubella-specific IL-10 production included HLA-A (*0201, *6801), HLA-B (*4901), and HLA-DRB1 (*1302). The class I A*0201 and A*6801 alleles were associated with both IFN-gamma and IL-10 secretion. These tentative associations need to be validated in larger studies with subjects of differing ethnicities. These results provide additional evidence that HLA genes may influence Th1- and Th2-specific cytokine response(s) following rubella immunization, which in turn can influence both cellular and humoral immune responses to rubella vaccination.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17215337      PMCID: PMC1797784          DOI: 10.1128/CVI.00247-06

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  46 in total

Review 1.  The HLA system. First of two parts.

Authors:  J Klein; A Sato
Journal:  N Engl J Med       Date:  2000-09-07       Impact factor: 91.245

Review 2.  Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures.

Authors:  S Goodbourn; L Didcock; R E Randall
Journal:  J Gen Virol       Date:  2000-10       Impact factor: 3.891

Review 3.  The HLA system. Second of two parts.

Authors:  J Klein; A Sato
Journal:  N Engl J Med       Date:  2000-09-14       Impact factor: 91.245

4.  Commentary: congenital rubella syndrome should not be a disease of poor countries.

Authors:  Stanley A Plotkin
Journal:  Pediatr Infect Dis J       Date:  2004-12       Impact factor: 2.129

5.  HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Jenna E Ryan; Robert A Vierkant; V Shane Pankratz; Steven J Jacobsen; Gregory A Poland
Journal:  Immunogenetics       Date:  2005-01-27       Impact factor: 2.846

6.  Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination.

Authors:  N Dhiman; I G Ovsyannikova; J E Ryan; R M Jacobson; R A Vierkant; V S Pankratz; S J Jacobsen; G A Poland
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

7.  Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Robert A Vierkant; Steven J Jacobsen; V Shane Pankratz; Gregory A Poland
Journal:  J Infect Dis       Date:  2005-01-14       Impact factor: 5.226

8.  Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children.

Authors:  Neelam Dhiman; Inna G Ovsyannikova; Robert M Jacobson; Robert A Vierkant; V Shane Pankratz; Steven J Jacobsen; Gregory A Poland
Journal:  Clin Immunol       Date:  2005-05       Impact factor: 3.969

9.  The contribution of HLA class I antigens in immune status following two doses of rubella vaccination.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Robert A Vierkant; Steven J Jacobsen; V Shane Pankratz; Gregory A Poland
Journal:  Hum Immunol       Date:  2004-12       Impact factor: 2.850

10.  Reducing the global burden of congenital rubella syndrome: report of the World Health Organization Steering Committee On Research Related To Measles and Rubella Vaccines and Vaccination, June 2004.

Authors:  Jennifer M Best; Carlos Castillo-Solorzano; John S Spika; Joseph Icenogle; John W Glasser; Nigel J Gay; Jon Andrus; Ann M Arvin
Journal:  J Infect Dis       Date:  2005-10-31       Impact factor: 5.226

View more
  19 in total

1.  Genetic basis for variation of vaccine response: our studies with rubella vaccine.

Authors:  Robert M Jacobson; Inna G Ovsyannikova; Gregory A Poland
Journal:  Paediatr Child Health       Date:  2009-12       Impact factor: 2.253

Review 2.  Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Richard B Kennedy; Iana H Haralambieva; Robert M Jacobson
Journal:  OMICS       Date:  2011-07-06

Review 3.  Factors That Influence the Immune Response to Vaccination.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Clin Microbiol Rev       Date:  2019-03-13       Impact factor: 26.132

4.  Predominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in healthy vaccinees.

Authors:  Neelam Dhiman; Iana H Haralambieva; Robert A Vierkant; V Shane Pankratz; Jenna E Ryan; Robert M Jacobson; Inna G Ovsyannikova; Gregory A Poland
Journal:  Cytokine       Date:  2010-02-01       Impact factor: 3.861

5.  Vaccine-induced control of viral shedding following rhesus cytomegalovirus challenge in rhesus macaques.

Authors:  Kristina Abel; Joy Martinez; Yujuan Yue; Simon F Lacey; Zhongde Wang; Lisa Strelow; Anindya Dasgupta; Zhongqi Li; Kimberli A Schmidt; Kristie L Oxford; Basel Assaf; Jeffrey A Longmate; Don J Diamond; Peter A Barry
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

6.  Polymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccination.

Authors:  Inna G Ovsyannikova; Iana H Haralambieva; Neelam Dhiman; Megan M O'Byrne; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

7.  Correlation between rubella antibody levels and cytokine measures of cell-mediated immunity.

Authors:  Pritish K Tosh; Richard B Kennedy; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  Viral Immunol       Date:  2009-12       Impact factor: 2.257

8.  Single nucleotide polymorphisms/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children.

Authors:  Inna G Ovsyannikova; Hannah M Salk; Beth R Larrabee; V Shane Pankratz; Gregory A Poland
Journal:  Immunogenetics       Date:  2015-09-02       Impact factor: 2.846

Review 9.  Application of pharmacogenomics to vaccines.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Pharmacogenomics       Date:  2009-05       Impact factor: 2.533

10.  Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination.

Authors:  Inna G Ovsyannikova; Jenna E Ryan; Robert A Vierkant; Megan M O'Byrne; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2009-02-05       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.